• 中国科技期刊卓越行动计划项目资助期刊
  • 中国精品科技期刊
  • EI
  • Scopus
  • CAB Abstracts
  • Global Health
  • 北大核心期刊
  • DOAJ
  • EBSCO
  • 中国核心学术期刊RCCSE A+
  • 中国科技核心期刊CSTPCD
  • JST China
  • FSTA
  • 中国农林核心期刊
  • 中国开放获取期刊数据库COAJ
  • CA
  • WJCI
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
中国精品科技期刊2020
蔡华昊,刘运柱,朱胜男,等. 复配益生元缓解便秘效果和途径探究[J]. 食品工业科技,2026,47(1):1−13. doi: 10.13386/j.issn1002-0306.2024120375.
引用本文: 蔡华昊,刘运柱,朱胜男,等. 复配益生元缓解便秘效果和途径探究[J]. 食品工业科技,2026,47(1):1−13. doi: 10.13386/j.issn1002-0306.2024120375.
CAI Huahao, LIU Yunzhu, ZHU Shengnan, et al. Effect and Approach of Combined Prebiotics in Alleviating Constipation[J]. Science and Technology of Food Industry, 2026, 47(1): 1−13. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2024120375.
Citation: CAI Huahao, LIU Yunzhu, ZHU Shengnan, et al. Effect and Approach of Combined Prebiotics in Alleviating Constipation[J]. Science and Technology of Food Industry, 2026, 47(1): 1−13. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2024120375.

复配益生元缓解便秘效果和途径探究

Effect and Approach of Combined Prebiotics in Alleviating Constipation

  • 摘要: 目的:便秘是一种常见的功能性胃肠疾病,需要可持续且无副作用的缓解手段。方法:本研究采用洛哌丁胺诱导小鼠便秘模型,评估了复配益生元对便秘的缓解作用。研究首先考察了复配益生元对便秘表观指标的影响,后续进一步对便秘相关胃肠调节递质,肠道屏障系统,结肠组织损伤情况,粪便内短链脂肪酸含量,和肠道菌群进行了检测。结果:复配益生元可以通过下调有害菌BilophilaAnaerovorax的相对丰度,上调有益菌IleibacteriumBifidobacterium的相对丰度,从而上调结肠内兴奋性胃肠调节递质含量(胃泌素和P物质),改善肠道屏障系统(上调粘蛋白2、闭锁蛋白、干细胞因子表达量,下调水通道蛋白3 mRNA表达量),改善结肠组织损伤,上调粪便中乙酸、丁酸含量,最终下调排首粒黑便时间(相比模型组缩短了27%),增加粪便含水率(相比模型组增加了46%),有效缓解便秘。而复配益生元与西梅汁复配后可以进一步上调有益菌OdoribacterFaecalibaculumDefluviitaleaceae_UCG-011的相对丰度,进一步上调结肠内胃泌素,胃动素含量,下调结肠内降钙素基因相关肽含量,上调粘蛋白2 mRNA表达量,上调粪便中乙酸、丁酸含量,增加小肠推进率(相比模型组增加了47%)和5 h内排便量(相比模型组增加了132%),从而更有效地缓解便秘。结论:复配益生元(每100 mL中主要含有低聚木糖3 g、水苏糖3 g、低聚半乳糖8 g)可缓解便秘,益生元与西梅汁复配后可以通过增强小肠推进率和提高菌群调节能力进而更有效地缓解便秘。本研究发现了西梅汁可以增强益生元缓解便秘的功效,为多种类低剂量益生元配方的开发提供了数据支持,为后续开发新型便秘缓解策略提供了科学依据。

     

    Abstract: Objective: Constipation is a common functional gastrointestinal disorder, necessitating sustainable and side-effect-free relief methods. Methods: This study investigated the efficacy of combined prebiotics in a loperamide-induced constipation mouse model. Further assessments included gut microbiota composition, fecal short-chain fatty acid levels, intestinal barrier-related markers, colonic tissue damage, and gastrointestinal regulatory neurotransmitters. Results: Combined prebiotics alleviated constipation by downregulating harmful bacteria (Bilophila, Anaerovorax) and upregulating beneficial bacteria (Ileibacterium, Bifidobacterium), thereby increasing excitatory gastrointestinal neurotransmitters (upregulating gastrin and substance P), improving the intestinal barrier (upregulating mucin-2, occludin, and stem cell factor mRNA expression while downregulating aquaporin-3 mRNA expression), repairing colonic tissue damage, and elevating fecal acetate and butyrate levels. These changes led to a 27% reduction in time to first black stool excretion and 46% increase in fecal water content compared to the model group. When combined with prune juice, the prebiotics formulation further enhanced the abundance of beneficial bacteria (Odoribacter, Faecalibaculum, Defluviitaleaceae_UCG-011), increased gastrin and motilin levels, decreased calcitonin gene-related peptide, upregulated mucin-2 mRNA, elevated fecal acetate and butyrate, improved small intestinal propulsion rate, and increased fecal output within 5 hours, demonstrating superior constipation relief. Conclusion: The study demonstrates that the combined prebiotics (containing 3 g xylooligosaccharides, 3 g stachyose, and 8 g galactooligosaccharides per 100 mL) effectively relieved constipation. Prebiotics combined with prune juice further enhancing efficacy through improved intestinal motility and microbiota modulation. These findings support the development of multi-component prebiotic formulations and reveal prune juice's potential to amplify prebiotic effects, providing a scientific basis for novel constipation management strategies.

     

/

返回文章
返回